An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

K ANTMAN; J CROWLEY; J. H DOROSHOW; J AISNER; R. P PUGH; R. B WEISS; B. A COOPER; G. H CLAMOND; L. H BAKER; S. P BALCERZAK; S. E RIVKIN; G. R WEISS; A ELIAS; R. B NATALE; R. M COOPER; B BARLOGIE; D. L TRUMP

doi:10.1200/JCO.1993.11.7.1276

Back

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

Journal article

Peer reviewed

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

K ANTMAN, J CROWLEY, J. H DOROSHOW, J AISNER, R. P PUGH, R. B WEISS, B. A COOPER, G. H CLAMOND, L. H BAKER, S. P BALCERZAK, …

Journal of clinical oncology, Vol.11(7), pp.1276-1285

1993

DOI: https://doi.org/10.1200/JCO.1993.11.7.1276

PMID: 8315425

Abstract

Biological and medical sciences

Medical sciences

Pharmacology. Drug treatments

Antineoplastic Agents

Chemotherapy

Metrics

21 Record Views

355 Times Cited - Web of Science

See more details

Details

Title: An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas
Creators: K ANTMAN - Dana-Farber cancer inst., Boston MA, United States
J CROWLEY - Dana-Farber cancer inst., Boston MA, United States
J. H DOROSHOW - Dana-Farber cancer inst., Boston MA, United States
J AISNER - Dana-Farber cancer inst., Boston MA, United States
R. P PUGH - Dana-Farber cancer inst., Boston MA, United States
R. B WEISS - Dana-Farber cancer inst., Boston MA, United States
B. A COOPER - Dana-Farber cancer inst., Boston MA, United States
G. H CLAMOND - Dana-Farber cancer inst., Boston MA, United States
L. H BAKER - Dana-Farber cancer inst., Boston MA, United States
S. P BALCERZAK - Dana-Farber cancer inst., Boston MA, United States
S. E RIVKIN - Dana-Farber cancer inst., Boston MA, United States
G. R WEISS - Dana-Farber cancer inst., Boston MA, United States
A ELIAS - Dana-Farber cancer inst., Boston MA, United States
R. B NATALE - Dana-Farber cancer inst., Boston MA, United States
R. M COOPER - Dana-Farber cancer inst., Boston MA, United States
B BARLOGIE - Dana-Farber cancer inst., Boston MA, United States
D. L TRUMP - Dana-Farber cancer inst., Boston MA, United States
Publication Details: Journal of clinical oncology, Vol.11(7), pp.1276-1285
Date published: 1993
Publisher: Lippincott Williams & Wilkins
Academic Unit: Lung Cancer/Thoracic Oncology Program
Language: English
Resource Type: Journal article
Identifiers: 991031654564604646